insights_auto
Zakaj je tečaj AMGN34 zrasel 2,61%?
Podrobneje raziščichevron_right
AMGN34:BVMF
Amgen
78,56 BRL
arrow_upward
+2,61%(+2,00) 1D
20. okt., 16:56:00 GMT -3 · BRL
search
Vsi simboli
| Simbol | Cena | Sprememba | Odstotna sprememba |
|---|
insights_autoGeneriranje najpomembnejših vpogledov za AMGN34 …
Odpri
78,00 BRL
Visoka
78,56 BRL
Nizka
77,92 BRL
Tržna kapitalizacija
237,31 mrd.
Povprečni promet
458,00
Promet
302,00
52-tedenski najvišji tečaj
83,06 BRL
52-tedenski najnižji tečaj
47,76 BRL
Št. izdanih delnic
540,63 mio.
Št. zaposlenih
32 tis.
Odpri
78,00 BRL
Visoka
78,56 BRL
Nizka
77,92 BRL
Tržna kapitalizacija
237,31 mrd.
Povprečni promet
458,00
Promet
302,00
52-tedenski najvišji tečaj
83,06 BRL
52-tedenski najnižji tečaj
47,76 BRL
Št. izdanih delnic
540,63 mio.
Št. zaposlenih
32 tis.
Novice
Iz spletnih virov in novičarskih partnerjev
The Motley Fool
·
pred 4 minutami
Amgen vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?
GuruFocus
·
pred 36 minutami
Amgen Inc (AMGN) Shares Surge 3.3% -- What GF Score of 85 Tells Investors
PR Newswire
·
pred 1 uro
AMGEN TO PRESENT AT THE EUROPEAN SOCIETY OF MEDICAL ONCOLOGY CONGRESS 2026
Investing.com
·
pred 3 urami
Amgen, Equifax among market cap stock movers on Tuesday
Profil
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Vizitka: Amgen
Generalni direktorRobert A. Bradway
Št. zaposlenih31,5 tis.
Ustanovljeno1980
SedežThousand Oaks, Kalifornija, Združene države Amerike
Sektor-
Spletno mestoamgen.com